Metabolic and pharmacokinetic considerations in the design of 2-phenyl substituted metyrapone derivatives: 2-methoxyphenylmetyrapone as a radioligand for functional diagnosis of adrenal pathology
- 1 November 1995
- journal article
- Published by Elsevier in Nuclear Medicine and Biology
- Vol. 22 (8), 1067-1074
- https://doi.org/10.1016/0969-8051(95)02034-9
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Structure-activity relationship study of the inhibition of adrenal cortical 11.beta.-hydroxylase by new metyrapone analogsJournal of Medicinal Chemistry, 1984
- Synthesis of N-oxide derivatives of metyrapone and their detection as in vitro metabolitesJournal of Pharmacy and Pharmacology, 1981
- Metabolism of metyrapone: 2—chromatographic and mass spectral properties of theN-oxides of metyrapone and metyrapolJournal of Mass Spectrometry, 1981
- A New and Superior Adrenal Imaging Agent,131I-6ß-Iodomethyl-19-Nor-Cholesterol (NP-59): Evaluation in HumansJournal of Clinical Endocrinology & Metabolism, 1977
- New inhibitors of steroid 11.beta.-hydroxylase. Structure-activity relation studies of metyrapone-like compoundsJournal of Medicinal Chemistry, 1977
- The binding of metyrapone to cytochrome P-450 and its inhibitory action on liver microsomal mixed-function oxidase reactionsBiochemical Journal, 1971